Liquidia Technologies is the only company in the world that can precisely engineer monodisperse drug particles in virtually unlimited compositions, sizes, or shapes. PRINT® technology integrates a proprietary particle molding technology with modular, roll-to-roll manufacturing to deliver scalable processes that meet cGMP requirements. The technology incorporates production practices from the semiconductor and materials industries. Through this approach, Liquidia and its partners can achieve a high level of control over physical and chemical characteristics of drug particles. Liquidia seeks to improve the efficacy, safety, and convenience of a wide range of medicines while reducing manufacturing complexity and cost.

http://liquidia.com/